Protein | +CTGF | + TGF-β1 | + TSP-1 | + VEGF | CTGF siRNA | TGF-β1 siRNA | TSP-1 siRNA | VEGF siRNA |
---|---|---|---|---|---|---|---|---|
CTGF | 3.99±0.14 *** | 1.51±0.02 ** | 0.96±0.02 | 1.57±0.02 ** | 0.33±0.01 ## | 0.75±0.02 # | 0.98±0.02 | 0.68±0.01 # |
TGF-β1 | 1.01±0.03 | 1.33±0.03 * | 1.04±0.03 | 1.99±0.08 ** | 1.03±0.04 | 0.23±0.01 ### | 1.07±0.04 | 0.72±0.01 ## |
TSP-1 | 1.48±0.05 * | 1.45±0.03 * | 1.45±0.02 * | 1.71±0.04 * | 0.73±0.01 # | 0.72±0.02 # | 0.54±0.02 ## | 0.48±0.01 ## |
VEGF | 1.74±0.07 ** | 3.61±0.20 ** | 0.99±0.03 | 1.94±0.05 ** | 0.42±0.01 ## | 0.61±0.01 # | 0.94±0.03 | 0.29±0.01 ## |
Results are expressed as the mean ± S.E.M. Each intervention treatment group (n=3) was compared to its mock treatment control (n = 3). *p < 0.05, **p < 0.01, ***p < 0.001 versus vehicle control. # p < 0.05, ## p < 0.01, ### p < 0.001 versus scramble siRNA.